Principal Financial Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151K Buy
19,710
+3,050
+18% +$20.9K ﹤0.01% 2114
2025
Q4
$33K Sell
16,660
-750
-4% -$1.7K ﹤0.01% 2167
2025
Q3
$42.8K Buy
17,410
+1,157
+7% +$2.98K ﹤0.01% 2220
2025
Q2
$42.9K Buy
16,253
+4,832
+42% +$13K ﹤0.01% 2195
2025
Q1
$34.4K Sell
11,421
-172
-1% -$521 ﹤0.01% 2134
2024
Q4
$29.7K Sell
11,593
-920
-7% -$3.83K ﹤0.01% 2184
2024
Q3
$46.5K Sell
12,513
-28,706
-70% -$133K ﹤0.01% 2182
2024
Q2
$261K Sell
41,219
-32,247
-44% -$213K ﹤0.01% 2088
2024
Q1
$395K Sell
73,466
-2,818
-4% -$12.8K ﹤0.01% 2035
2023
Q4
$383K Buy
76,284
+64
+0.1% +$201 ﹤0.01% 2008
2023
Q3
$129K Buy
76,220
+2,166
+3% +$4.35K ﹤0.01% 2241
2023
Q2
$206K Buy
74,054
+9,246
+14% +$26.1K ﹤0.01% 2176
2023
Q1
$118K Sell
64,808
-4,164
-6% -$12.9K ﹤0.01% 2279
2022
Q4
$350K Buy
68,972
+11,801
+21% +$64.8K ﹤0.01% 2065
2022
Q3
$285K Buy
57,171
+1,678
+3% +$7.65K ﹤0.01% 2094
2022
Q2
$206K Buy
55,493
+9,925
+22% +$39.9K ﹤0.01% 2296
2022
Q1
$256K Sell
45,568
-1,248
-3% -$7.66K ﹤0.01% 2279
2021
Q4
$285K Buy
46,816
+25,163
+116% +$189K ﹤0.01% 2258
2021
Q3
$211K Sell
21,653
-3,510
-14% -$38.6K ﹤0.01% 2417
2021
Q2
$359K Buy
25,163
+1,173
+5% +$19.4K ﹤0.01% 2299
2021
Q1
$570K Buy
23,990
+1,690
+8% +$43.8K ﹤0.01% 2124
2020
Q4
$297K Buy
22,300
+2,284
+11% +$22K ﹤0.01% 2241
2020
Q3
$139K Sell
20,016
-990
-5% -$9.87K ﹤0.01% 2246
2020
Q2
$258K Buy
+21,006
New +$119K ﹤0.01% 2123

Other funds holding IBRX